The way mesothelioma spreads depends largely on the location of the original tumor and the cell type involved. The most common starting point is the lining of the lungs, known as the pleura, but it can also originate in the abdominal lining, heart lining, or the lining of the testes. The tumor's histology, or cell type, affects its growth and metastatic potential. For example, epithelioid mesothelioma tends to spread more slowly and responds better to treatment, whereas sarcomatoid mesothelioma is more aggressive, often spreading rapidly and invading neighboring tissues or distant organs. The disease's stage reflects how far it has advanced, with early stages localized and later stages involving widespread metastasis.
As mesothelioma advances, symptoms associated with metastasis tend to become more pronounced and diverse, depending on the affected organs. Patients may experience symptoms such as significant fatigue, swelling, difficulty swallowing, or neurological issues if the brain or spinal cord are involved. Treatment options for metastatic mesothelioma are generally limited, especially when the disease has spread to vital organs. Unlike early stages, where surgery might be considered, late-stage treatment mainly aims to slow tumor growth, reduce symptoms, and improve quality of life through systemic therapies like chemotherapy, immunotherapy, and clinical trials. Supportive and palliative care play vital roles in helping patients manage symptoms and maintain comfort during this challenging phase of the disease journey.
